Thioredoxin-Disulfide Reductase
"Thioredoxin-Disulfide Reductase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A FLAVOPROTEIN enzyme that catalyzes the oxidation of THIOREDOXINS to thioredoxin disulfide in the presence of NADP+. It was formerly listed as EC 1.6.4.5
| Descriptor ID |
D013880
|
| MeSH Number(s) |
D08.811.682.667.750 D12.776.331.971
|
| Concept/Terms |
Thioredoxin-Disulfide Reductase- Thioredoxin-Disulfide Reductase
- Reductase, Thioredoxin-Disulfide
- Thioredoxin Disulfide Reductase
- Thioredoxin Reductase (NADPH)
- Thioredoxin Reductase
- Reductase, Thioredoxin
- NADP-Thioredoxin Reductase
- NADP Thioredoxin Reductase
- Reductase, NADP-Thioredoxin
- NADPH-Thioredoxin Reductase
- NADPH Thioredoxin Reductase
- Reductase, NADPH-Thioredoxin
|
Below are MeSH descriptors whose meaning is more general than "Thioredoxin-Disulfide Reductase".
Below are MeSH descriptors whose meaning is more specific than "Thioredoxin-Disulfide Reductase".
This graph shows the total number of publications written about "Thioredoxin-Disulfide Reductase" by people in this website by year, and whether "Thioredoxin-Disulfide Reductase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thioredoxin-Disulfide Reductase" by people in Profiles.
-
Thioredoxin reductase is a major regulator of metabolism in leukemia cells. Oncogene. 2021 08; 40(33):5236-5246.
-
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis. Cancer Res. 2019 01 01; 79(1):125-132.
-
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms. Oncotarget. 2014 Oct 15; 5(19):9118-32.
-
Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione. FASEB J. 2013 Apr; 27(4):1394-403.